A phase 1b dose-escalation study of TRC105 (anti-endoglin antibody) in combination with axitinib in patients with metastatic renal cell carcinoma (mRCC).
Toni K. Choueiri
Research Funding - TRACON Pharma
Edwin M. Posadas
Research Funding - TRACON Pharma
Guru Sonpavde
Research Funding - TRACON Pharma
Robert A. Figlin
Research Funding - TRACON Pharma
Meghara K. Walsh
Research Funding - TRACON Pharma
Kevin C. Wall
Research Funding - TRACON Pharma
Ben K. Seon
No relevant relationships to disclose
Manoj A. Jivani
Employment or Leadership Position - TRACON Pharma
Stock Ownership - TRACON Pharma
Bonne J. Adams
Employment or Leadership Position - TRACON Pharma
Stock Ownership - TRACON Pharma
Charles P. Theuer
Employment or Leadership Position - TRACON Pharma
Stock Ownership - TRACON Pharma